Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Health Law Journal
|
June 20, 2009
Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context
Loria Knowles, Tania Bubela
Stem Cells and Development
|
December 6, 2013
Value-engineered translation for regenerative medicine: meeting the needs of health systems
Tania Bubela, Christopher McCabe
Regenerative Medicine
|
August 4, 2015
Current practices and reform proposals for the regulation of advanced medicinal products in Canada
Sowmya Viswanathan, Tania Bubela
The American Journal of Managed Care
|
April 2, 2015
Value-engineered translation: developing biotherapeutics that align with health-system needs
Tania Bubela, Christopher McCabe
Stem Cell Reviews and Reports
|
October 4, 2015
Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea
Noomi Weinryb, Tania Bubela
BMC Medical Ethics
|
July 17, 2014
Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications
Shelly Benjaminy, Tania Bubela
Omics : a Journal of Integrative Biology
|
February 21, 2014
Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics
Amrita Mishra, Tania Bubela
Journal of Law and the Biosciences
|
June 19, 2023
Should Canada adopt managed access agreements in Canada for expensive drugs?
Melanie McPhail, Tania Bubela
Healthcarepapers
|
January 24, 2023
Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context?
Melanie McPhail, Tania Bubela
The American Journal of Bioethics : AJOB
|
March 17, 2007
Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate
Timothy Caulfield, Tania Bubela
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Health Law Journal
|
June 20, 2009
Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context
Loria Knowles, Tania Bubela
Stem Cells and Development
|
December 6, 2013
Value-engineered translation for regenerative medicine: meeting the needs of health systems
Tania Bubela, Christopher McCabe
Regenerative Medicine
|
August 4, 2015
Current practices and reform proposals for the regulation of advanced medicinal products in Canada
Sowmya Viswanathan, Tania Bubela
The American Journal of Managed Care
|
April 2, 2015
Value-engineered translation: developing biotherapeutics that align with health-system needs
Tania Bubela, Christopher McCabe
Stem Cell Reviews and Reports
|
October 4, 2015
Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea
Noomi Weinryb, Tania Bubela
BMC Medical Ethics
|
July 17, 2014
Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications
Shelly Benjaminy, Tania Bubela
Omics : a Journal of Integrative Biology
|
February 21, 2014
Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics
Amrita Mishra, Tania Bubela
Journal of Law and the Biosciences
|
June 19, 2023
Should Canada adopt managed access agreements in Canada for expensive drugs?
Melanie McPhail, Tania Bubela
Healthcarepapers
|
January 24, 2023
Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context?
Melanie McPhail, Tania Bubela
The American Journal of Bioethics : AJOB
|
March 17, 2007
Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate
Timothy Caulfield, Tania Bubela
Page
of 9